Cargando…

Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters

INTRODUCTION: Tumor necrosis factor (TNF) is a cytokine able to exert anti-tumor activity in various models and modes of applications. However, the exact mechanism mediating the in vivo anti-tumor effect of TNF has not yet been clarified. MATERIALS AND METHODS: The effects of intratumoral injection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koszałka, Patrycja, Szmit, Ewa, Myśliwski, Andrzej, Bigda, Jacek
Formato:	Texto
Lenguaje:	English
Publicado:	Birkhäuser-Verlag 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766459/ https://www.ncbi.nlm.nih.gov/pubmed/17659374 http://dx.doi.org/10.1007/s00005-007-0031-9

Ejemplares similares

Specific Activation of A(3), A(2A) and A(1) Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration
por: Koszałka, Patrycja, et al.
Publicado: (2016)

U937 variant cells as a model of apoptosis without cell disintegration
por: Stasiłojć, Grzegorz, et al.
Publicado: (2013)

Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
por: Billmeier, Ulrike, et al.
Publicado: (2016)

Transplantable Melanomas in Hamsters and Gerbils as Models for Human Melanoma. Sensitization in Melanoma Radiotherapy—From Animal Models to Clinical Trials
por: Śniegocka, Martyna, et al.
Publicado: (2018)

In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors
por: Tsutsumi, Yasuo, et al.
Publicado: (1996)

A case of leukocytoclastic vasculitis associated with anti-tumor necrosis factor therapy
por: Sikorska, Dorota, et al.
Publicado: (2018)

Predicting the future of anti-tumor necrosis factor therapy
por: Verweij, Cornelis L
Publicado: (2009)

Golimumab: A Novel Anti-Tumor Necrosis Factor
por: Rossini, Maurizio, et al.
Publicado: (2013)

Tumor necrosis factor inhibitors – state of knowledge
por: Lis, Krzysztof, et al.
Publicado: (2014)

Chemometric Evaluation of Urinary Steroid Hormone Levels as Potential Biomarkers of Neuroendocrine Tumors
por: Plenis, Alina, et al.
Publicado: (2013)

Treatment of Subcorneal Pustular Dermatosis (Sneddon-Wilkinson Disease) With Anti-Tumor Necrosis Factor Alpha
por: Guerin, Clemence, et al.
Publicado: (2021)

Production and Enhanced Anti‐tumor Activity of Tumor Necrosis Factor in Mice Treated with Cyclophosphamide
por: Noso, Yoshihiro, et al.
Publicado: (1990)

Alopecia secondary to anti-tumor necrosis factor-alpha therapy()
por: Ribeiro, Lara Beatriz Prata, et al.
Publicado: (2015)

Anti-tumor necrosis factor therapy in inflammatory bowel disease
por: Ramakrishna, B.S.
Publicado: (2017)

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
por: Park, Jihye, et al.
Publicado: (2018)

Neutrophil Extracellular Traps Correlate with Tumor Necrosis and Size in Human Malignant Melanoma Metastases
por: Weide, Lennard Marten, et al.
Publicado: (2023)

Tumor Necrosis Factor Induces Tumor Promoting and Anti-Tumoral Effects on Pancreatic Cancer via TNFR1
por: Chopra, Martin, et al.
Publicado: (2013)

EFFECTS OF HORMONES ON THE ADRENAL NECROSIS PRODUCED BY BESNOITIA JELLISONI IN GOLDEN HAMSTERS
por: Frenkel, J. K.
Publicado: (1956)

Purification and properties of tyrosinase isoenzymes from hamster melanoma.
por: Pomerantz, S. H., et al.
Publicado: (1973)

Repair of local bone erosions by combined treatment with parathyroid hormone, osteoprotegerin and anti-tumor necrosis factor in tumor necrosis factor-transgenic mice
por: Redlich, K, et al.
Publicado: (2003)

Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy
por: Winthrop, Kevin L., et al.
Publicado: (2009)

Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases
por: Kalden, Joachim R
Publicado: (2002)

Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus()
por: Almoallim, Hani, et al.
Publicado: (2012)

A Case of Sarcoidosis Associated With Anti–Tumor Necrosis Factor Treatment
por: Baha, Ayse, et al.
Publicado: (2015)

The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
por: Golay, Josée, et al.
Publicado: (2020)

SARCOMAS IN HAMSTERS AFTER INJECTION WITH ROUS CHICKEN TUMOR MATERIAL
por: Ahlström, C. G., et al.
Publicado: (1962)

Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor
Publicado: (1986)

Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2016)

Anti-Tumoral and Anti-Angiogenic Effects of Low-Diluted Phenacetinum on Melanoma
por: Fuselier, Camille, et al.
Publicado: (2021)

A Collision Tumor Consisting of Granular Cell Tumor and Adenocarcinoma in the Uterus of an Aged Djungarian Hamster
por: Golbar, Hossain M., et al.
Publicado: (2011)

Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)

Tumor Necrosis Factor and Splenectomy
por: Yavaşoğlu, İrfan
Publicado: (2016)

Necroptosis, tumor necrosis and tumorigenesis
por: Liu, Zheng-gang, et al.
Publicado: (2019)

Melanoma Stem Cell-Like Phenotype and Significant Suppression of Immune Response within a Tumor Are Regulated by TRIM28 Protein
por: Czerwinska, Patrycja, et al.
Publicado: (2020)

Visualization and Quantitative 3D Analysis of Intraocular Melanoma and Its Vascularization in a Hamster Eye
por: Leszczyński, Bartosz, et al.
Publicado: (2018)

RNA-directed DNA-polymerase activity in Greene hamster melanoma.
por: Reid, T. W., et al.
Publicado: (1973)

Characterization of Anti-Cancer Activities of Violacein: Actions on Tumor Cells and the Tumor Microenvironment
por: Dahlem, Charlotte, et al.
Publicado: (2022)

Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
por: Xynos, Ioannis D., et al.
Publicado: (2009)

Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis
por: Lee, Jeong-Won, et al.
Publicado: (2015)

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
por: Scheinberg, Morton, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3ff3qm6lvrj85sppa9hntmei3s